Anywhere Real Estate (NYSE:HOUS) reported quarterly sales of $1.32 billion which missed the analyst consensus estimate of $1.40 billion by 5.50 percent. This is a 32.98 percent decrease over sales of $1.97 billion the same period last year.
Puma Biotech’s Nerlynx Wins Canadian Approval In HER2-Positive Metastatic Breast Cancer
Health Canada has approved Puma Biotechnology Inc’s (NASDAQ:PBYI) Nerlynx (neratinib) in combination with capecitabine for metastatic HER2-overexpressed/amplified breast cancer, who…
